Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Everybody responds differently. Lilly's Triple Agonist, Retatrutide, Successful in Two Additional Phase 3 Obesity Trials, Delivering Significant Improvements in Weight and A1C
no video visit unless clinically necessary Initial review typically completed within 2448 hours after intake Treatments Offered Weekly GLP-1 injections: Ozempic, Wegovy, Mounjaro, Zepbound, compounded semaglutide, and compounded liraglutide Daily (once or twice) oral weight-loss medications: bupropion, metformin, topiramate, B12, naltrexone App-based sleep, nutrition, and exercise guidance: included Additional services : birth control, ED treatment, skincare, mental health Bottom Line Hims and Hers is a solid option for adults who want GLP-1 access through a trusted, gender-specific telehealth brand
NHS vs Private Access To qualify for either medication on the NHS, you generally need a BMI of 35 or above and at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol
For anyone running a structured weight loss protocol , this is usually the most practical starting point
US$ 25.19
US$ 22.42
US$ 21.87
